APO Research
Talk to an analyst

APO RESEARCH · REPORT

Helicobacter Pylori Infection Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Helicobacter Pylori Infection Treatment Industry Growth and Trends Forecast to 2032

4 July 2026102 pages

Choose your research edition.

Industry ResearchHelicobacter Pylori Infection Treatment Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Helicobacter Pylori Infection Treatment Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Helicobacter Pylori Infection Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Helicobacter Pylori Infection Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Helicobacter Pylori Infection Treatment Market Analysis and Forecast 2026-2032172 pages · $4,950 USD

Market perspective

According to APO Research, the global Helicobacter Pylori Infection Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Helicobacter Pylori Infection Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Helicobacter Pylori Infection Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Helicobacter Pylori Infection Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Helicobacter Pylori Infection Treatment market include Cumberland Pharmaceuticals, Eisai Co., Bio-Rad Laboratories, F. Hoffmann-La Roche, Alpha Laboratories, Biohit, Phathom Pharmaceuticals, Redhill Biopharma and Takeda Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Helicobacter Pylori Infection Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Helicobacter Pylori Infection Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Helicobacter Pylori Infection Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Helicobacter Pylori Infection Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Helicobacter Pylori Infection Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Helicobacter Pylori Infection Treatment Market by Company

Cumberland Pharmaceuticals

Eisai Co.

Bio-Rad Laboratories

F. Hoffmann-La Roche

Alpha Laboratories

Biohit

Phathom Pharmaceuticals

Redhill Biopharma

Takeda Pharmaceuticals

AbbVie

Helicobacter Pylori Infection Treatment Segment by Type

Bismuth-quadruple Therapy

Concomitant Therapy

Levofloxacin Triple Therapy

Bismuth Therapy

High-dose Dual Therapy

Helicobacter Pylori Infection Treatment Segment by Application

Hospitals

Diagnostics Laboratories

Clinics

Helicobacter Pylori Infection Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Helicobacter Pylori Infection Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Helicobacter Pylori Infection Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Helicobacter Pylori Infection Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Helicobacter Pylori Infection Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Helicobacter Pylori Infection Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Helicobacter Pylori Infection Treatment Market Share by Region (2021-2026) Table 4. Global Helicobacter Pylori Infection Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Helicobacter Pylori Infection Treatment Market Share by Region (2027-2032) Table 6. Global Helicobacter Pylori Infection Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Helicobacter Pylori Infection Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Helicobacter Pylori Infection Treatment Market Size Share by Type (2021-2026) Table 9. Global Helicobacter Pylori Infection Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Helicobacter Pylori Infection Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Helicobacter Pylori Infection Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Helicobacter Pylori Infection Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Helicobacter Pylori Infection Treatment Market Size Share by Application (2021-2026) Table 24. Global Helicobacter Pylori Infection Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Helicobacter Pylori Infection Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Helicobacter Pylori Infection Treatment Industry Trends Table 37. Helicobacter Pylori Infection Treatment Industry Drivers Table 38. Helicobacter Pylori Infection Treatment Industry Opportunities and Challenges Table 39. Helicobacter Pylori Infection Treatment Industry Restraints Table 40. Global Helicobacter Pylori Infection Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Helicobacter Pylori Infection Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Helicobacter Pylori Infection Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Helicobacter Pylori Infection Treatment Key Company Headquarters & Area Served Table 44. Global Helicobacter Pylori Infection Treatment Company, Product Type & Application Table 45. Global Helicobacter Pylori Infection Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Helicobacter Pylori Infection Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Cumberland Pharmaceuticals Company Information Table 49. Cumberland Pharmaceuticals Business Overview Table 50. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio Table 52. Cumberland Pharmaceuticals Recent Development Table 53. Eisai Co. Company Information Table 54. Eisai Co. Business Overview Table 55. Eisai Co. Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Eisai Co. Helicobacter Pylori Infection Treatment Product Portfolio Table 57. Eisai Co. Recent Development Table 58. Bio-Rad Laboratories Company Information Table 59. Bio-Rad Laboratories Business Overview Table 60. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Portfolio Table 62. Bio-Rad Laboratories Recent Development Table 63. F. Hoffmann-La Roche Company Information Table 64. F. Hoffmann-La Roche Business Overview Table 65. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Portfolio Table 67. F. Hoffmann-La Roche Recent Development Table 68. Alpha Laboratories Company Information Table 69. Alpha Laboratories Business Overview Table 70. Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Alpha Laboratories Helicobacter Pylori Infection Treatment Product Portfolio Table 72. Alpha Laboratories Recent Development Table 73. Biohit Company Information Table 74. Biohit Business Overview Table 75. Biohit Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Biohit Helicobacter Pylori Infection Treatment Product Portfolio Table 77. Biohit Recent Development Table 78. Phathom Pharmaceuticals Company Information Table 79. Phathom Pharmaceuticals Business Overview Table 80. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio Table 82. Phathom Pharmaceuticals Recent Development Table 83. Redhill Biopharma Company Information Table 84. Redhill Biopharma Business Overview Table 85. Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Redhill Biopharma Helicobacter Pylori Infection Treatment Product Portfolio Table 87. Redhill Biopharma Recent Development Table 88. Takeda Pharmaceuticals Company Information Table 89. Takeda Pharmaceuticals Business Overview Table 90. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio Table 92. Takeda Pharmaceuticals Recent Development Table 93. AbbVie Company Information Table 94. AbbVie Business Overview Table 95. AbbVie Helicobacter Pylori Infection Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. AbbVie Helicobacter Pylori Infection Treatment Product Portfolio Table 97. AbbVie Recent Development Table 98. North America Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. North America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million) Table 100. North America Helicobacter Pylori Infection Treatment Market Share by Country (2021-2026) Table 101. North America Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. North America Helicobacter Pylori Infection Treatment Market Share Forecast by Country (2027-2032) Table 103. Europe Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million) Table 105. Europe Helicobacter Pylori Infection Treatment Market Share by Country (2021-2026) Table 106. Europe Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Europe Helicobacter Pylori Infection Treatment Market Share Forecast by Country (2027-2032) Table 108. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million) Table 110. Asia-Pacific Helicobacter Pylori Infection Treatment Market Share by Country (2021-2026) Table 111. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Asia-Pacific Helicobacter Pylori Infection Treatment Market Share Forecast by Country (2027-2032) Table 113. Latin America Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Latin America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million) Table 115. Latin America Helicobacter Pylori Infection Treatment Market Share by Country (2021-2026) Table 116. Latin America Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Latin America Helicobacter Pylori Infection Treatment Market Share Forecast by Country (2027-2032) Table 118. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026) & (US$ Million) Table 120. Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Country (2021-2026) Table 121. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Middle East & Africa Helicobacter Pylori Infection Treatment Market Share Forecast by Country (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Helicobacter Pylori Infection Treatment Product Image Figure 3. Global Helicobacter Pylori Infection Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Helicobacter Pylori Infection Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Helicobacter Pylori Infection Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Helicobacter Pylori Infection Treatment Market Share by Region (2021-2032) Figure 7. North America Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Bismuth-quadruple Therapy Image Figure 13. Global Bismuth-quadruple Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Concomitant Therapy Image Figure 15. Global Concomitant Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Levofloxacin Triple Therapy Image Figure 17. Global Levofloxacin Triple Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Bismuth Therapy Image Figure 19. Global Bismuth Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. High-dose Dual Therapy Image Figure 21. Global High-dose Dual Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Helicobacter Pylori Infection Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Helicobacter Pylori Infection Treatment Market Share by Type 2025 VS 2032 Figure 24. North America Helicobacter Pylori Infection Treatment Market Size Share by Type (2021-2032) Figure 25. Europe Helicobacter Pylori Infection Treatment Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Share by Type (2021-2032) Figure 27. Latin America Helicobacter Pylori Infection Treatment Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Helicobacter Pylori Infection Treatment Market Size Share by Type (2021-2032) Figure 29. Hospitals Image Figure 30. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Diagnostics Laboratories Image Figure 32. Global Diagnostics Laboratories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Clinics Image Figure 34. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Helicobacter Pylori Infection Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Helicobacter Pylori Infection Treatment Market Share by Application 2025 VS 2032 Figure 37. North America Helicobacter Pylori Infection Treatment Market Size Share by Application (2021-2032) Figure 38. Europe Helicobacter Pylori Infection Treatment Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Share by Application (2021-2032) Figure 40. Latin America Helicobacter Pylori Infection Treatment Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Helicobacter Pylori Infection Treatment Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Helicobacter Pylori Infection Treatment Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Helicobacter Pylori Infection Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Helicobacter Pylori Infection Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 47. Europe Helicobacter Pylori Infection Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Helicobacter Pylori Infection Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 50. Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Helicobacter Pylori Infection Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 53. Latin America Helicobacter Pylori Infection Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Helicobacter Pylori Infection Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 56. Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Helicobacter Pylori Infection Treatment Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Bismuth-quadruple Therapy
  • Concomitant Therapy
  • Levofloxacin Triple Therapy
  • Bismuth Therapy
  • High-dose Dual Therapy
Applications
  • Hospitals
  • Diagnostics Laboratories
  • Clinics
Companies covered
  • Cumberland Pharmaceuticals
  • Eisai Co.
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Alpha Laboratories
  • Biohit
  • Phathom Pharmaceuticals
  • Redhill Biopharma
  • Takeda Pharmaceuticals
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Helicobacter Pylori Infection Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Helicobacter Pylori Infection Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Helicobacter Pylori Infection Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Helicobacter Pylori Infection Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Helicobacter Pylori Infection Treatment Market Size (2021-2032)
  8. 1.5.1 North America Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Growth Rate (2021-2032)
2 Helicobacter Pylori Infection Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Bismuth-quadruple Therapy
  3. 2.1.2 Concomitant Therapy
  4. 2.1.3 Levofloxacin Triple Therapy
  5. 2.1.4 Bismuth Therapy
  6. 2.1.5 High-dose Dual Therapy
  7. 2.2 Global Helicobacter Pylori Infection Treatment Market Size by Type
  8. 2.2.1 Global Helicobacter Pylori Infection Treatment Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Helicobacter Pylori Infection Treatment Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Helicobacter Pylori Infection Treatment Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Helicobacter Pylori Infection Treatment Market Size by Regions
  12. 2.3.1 North America Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Helicobacter Pylori Infection Treatment Market Size Breakdown by Type (2021-2026)
3 Helicobacter Pylori Infection Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Diagnostics Laboratories
  4. 3.1.3 Clinics
  5. 3.2 Global Helicobacter Pylori Infection Treatment Market Size by Application
  6. 3.2.1 Global Helicobacter Pylori Infection Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Helicobacter Pylori Infection Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Helicobacter Pylori Infection Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Helicobacter Pylori Infection Treatment Market Size by Regions
  10. 3.3.1 North America Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Helicobacter Pylori Infection Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Helicobacter Pylori Infection Treatment Industry Trends
  2. 4.2 Helicobacter Pylori Infection Treatment Industry Drivers
  3. 4.3 Helicobacter Pylori Infection Treatment Industry Opportunities and Challenges
  4. 4.4 Helicobacter Pylori Infection Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Helicobacter Pylori Infection Treatment Revenue (2021-2026)
  2. 5.2 Global Helicobacter Pylori Infection Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Helicobacter Pylori Infection Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Helicobacter Pylori Infection Treatment Company, Product Type & Application
  5. 5.5 Global Helicobacter Pylori Infection Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Helicobacter Pylori Infection Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Helicobacter Pylori Infection Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Helicobacter Pylori Infection Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Cumberland Pharmaceuticals
  2. 6.1.1 Cumberland Pharmaceuticals Company Information
  3. 6.1.2 Cumberland Pharmaceuticals Business Overview
  4. 6.1.3 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Cumberland Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
  6. 6.1.5 Cumberland Pharmaceuticals Recent Developments
  7. 6.2 Eisai Co.
  8. 6.2.1 Eisai Co. Company Information
  9. 6.2.2 Eisai Co. Business Overview
  10. 6.2.3 Eisai Co. Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Co. Helicobacter Pylori Infection Treatment Product Portfolio
  12. 6.2.5 Eisai Co. Recent Developments
  13. 6.3 Bio-Rad Laboratories
  14. 6.3.1 Bio-Rad Laboratories Company Information
  15. 6.3.2 Bio-Rad Laboratories Business Overview
  16. 6.3.3 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bio-Rad Laboratories Helicobacter Pylori Infection Treatment Product Portfolio
  18. 6.3.5 Bio-Rad Laboratories Recent Developments
  19. 6.4 F. Hoffmann-La Roche
  20. 6.4.1 F. Hoffmann-La Roche Company Information
  21. 6.4.2 F. Hoffmann-La Roche Business Overview
  22. 6.4.3 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 F. Hoffmann-La Roche Helicobacter Pylori Infection Treatment Product Portfolio
  24. 6.4.5 F. Hoffmann-La Roche Recent Developments
  25. 6.5 Alpha Laboratories
  26. 6.5.1 Alpha Laboratories Company Information
  27. 6.5.2 Alpha Laboratories Business Overview
  28. 6.5.3 Alpha Laboratories Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Alpha Laboratories Helicobacter Pylori Infection Treatment Product Portfolio
  30. 6.5.5 Alpha Laboratories Recent Developments
  31. 6.6 Biohit
  32. 6.6.1 Biohit Company Information
  33. 6.6.2 Biohit Business Overview
  34. 6.6.3 Biohit Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Biohit Helicobacter Pylori Infection Treatment Product Portfolio
  36. 6.6.5 Biohit Recent Developments
  37. 6.7 Phathom Pharmaceuticals
  38. 6.7.1 Phathom Pharmaceuticals Company Information
  39. 6.7.2 Phathom Pharmaceuticals Business Overview
  40. 6.7.3 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Phathom Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
  42. 6.7.5 Phathom Pharmaceuticals Recent Developments
  43. 6.8 Redhill Biopharma
  44. 6.8.1 Redhill Biopharma Company Information
  45. 6.8.2 Redhill Biopharma Business Overview
  46. 6.8.3 Redhill Biopharma Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Redhill Biopharma Helicobacter Pylori Infection Treatment Product Portfolio
  48. 6.8.5 Redhill Biopharma Recent Developments
  49. 6.9 Takeda Pharmaceuticals
  50. 6.9.1 Takeda Pharmaceuticals Company Information
  51. 6.9.2 Takeda Pharmaceuticals Business Overview
  52. 6.9.3 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Takeda Pharmaceuticals Helicobacter Pylori Infection Treatment Product Portfolio
  54. 6.9.5 Takeda Pharmaceuticals Recent Developments
  55. 6.10 AbbVie
  56. 6.10.1 AbbVie Company Information
  57. 6.10.2 AbbVie Business Overview
  58. 6.10.3 AbbVie Helicobacter Pylori Infection Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 AbbVie Helicobacter Pylori Infection Treatment Product Portfolio
  60. 6.10.5 AbbVie Recent Developments
7 North America
  1. 7.1 North America Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Helicobacter Pylori Infection Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst